Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel liquid-phase cyclization method ensures high purity and low racemization for scalable pharmaceutical intermediate manufacturing supply chains reducing costs significantly.
Patent CN114085161B offers a cost-effective route for 5-ALA-HCl. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Patent CN115557948A details a metal-free electrochemical method for C3 selenization, offering green synthesis and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN110655456B details Co-catalyzed hydrogenation of E/Z mixed olefins. Offers high ee and conversion for pharmaceutical intermediates.
Novel one-step Mitsunobu route for rabeprazole thioether. Eliminates chlorination, reduces corrosion, ensures high purity >98% for reliable pharmaceutical intermediate supply.
Patent CN101503387B details a mild benzyne-mediated cyclization for high-purity indole derivatives, offering significant cost reduction in API manufacturing and scalable production.
Novel patent CN104109182A details high purity gemcitabine hydrochloride synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105566367B details a palladium-free synthesis route for high-purity intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel copper-catalyzed route for 4 4 diamino diphenyl ether offers mild conditions and high purity ensuring reliable supply chain stability and cost efficiency.
Patent CN103554117B enables high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing with metal-free catalysis.
Novel aniline-based route for 4,4'-diaminodiphenyl ether. Reduces cost and pollution. Reliable supply for polymer and pharma applications.
Novel iodine-catalyzed method for phenolic compounds. Metal-free, aqueous phase system ensures high purity and supply chain reliability for pharmaceutical intermediates.
Novel synthesis route for diazabicyclo derivatives offering enhanced structural diversity for pharmaceutical intermediate manufacturing and supply chain reliability globally.
Patent CN102439010A details a scalable copper-catalyzed cyclization for gamma secretase inhibitors, offering high purity and reduced impurities for pharmaceutical manufacturing.
Advanced post-processing technology reduces V320 and NDMA impurities in Valsartan manufacturing. Ensures supply chain safety and regulatory compliance for global pharmaceutical partners.
Advanced coupled synthesis technology for Vitamin B intermediates. Delivers high-purity Alpha-Acetyl-Gamma-Butyrolactone with optimized supply chain efficiency and cost reduction.
Patent CN112063670A reveals a stable adenylate cyclase method for cAMP production, offering reliable pharmaceutical intermediates supply with significant cost and environmental advantages.
Patent CN116283699B reveals a visible-light driven method for high-purity fluoroalkyl pyrrolidines offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel 2-step route for Selpercatinib via CN111057075B. High purity >99.5%, mild conditions, cost-effective manufacturing for RET inhibitors.
Patent CN106397163A reveals novel dichlorination route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing globally.